← Back to All Filings

Regeneron EVP Covers Taxes with $1.8M in Stock (REGN)

Low SignificanceDecember 11, 2025 at 5:06:27 PM EST

REGENERON PHARMACEUTICALS, INC.

$REGN4CIK: 0000872589

Subscribe to track REGN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Regeneron EVP Covers Taxes with $1.8M in Stock (REGN)

Company: REGENERON PHARMACEUTICALS, INC. (REGN) Form: 4 | Filed: 2025-12-11 Significance: Low

Insider: Van Plew Daniel P Title: EVP & General Mgr, Industrial | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 2,552 • Price: $701.51 • Value: $1,790,254 • Owned After: 35,178 (Direct & Indirect)

Key Insight: This was a non-discretionary disposition of shares to cover tax liabilities related to the vesting of restricted stock, not an open-market sale. Such transactions typically have low informational value for investors.

Market Context: The transaction represents a negligible fraction (0.0025%) of the company's shares outstanding and has minimal market impact given Regeneron's $72.89B market cap.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: REGENERON PHARMACEUTICALS, INC. (REGN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer disposed of $1.8M in stock to cover tax obligations from vesting shares, a routine and non-discretionary event.
  • Market Impact: Negligible. The transaction is too small relative to Regeneron's market capitalization and public float to influence the stock price.

Company Information

FieldValue
CompanyREGENERON PHARMACEUTICALS, INC.
Ticker SymbolREGN
CIK0000872589
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameVan Plew Daniel P
CIK0001411984
Title/PositionEVP & General Mgr, Industrial
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-09
Transaction CodeF - Payment of tax liability by withholding securities
Security TypeCommon Stock
Shares Involved2,552
Price Per Share$701.51
Total Value$1,790,253.52
Shares Owned After35,178 (including direct and indirect holdings)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,790,253.52
% of Market Cap0.0025%
Shares Transacted2,552
% of Shares Outstanding0.0025%
Post-Transaction Ownership35,178 shares (0.034% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: As a large-cap company with a market capitalization of $72.89 billion, a transaction of $1.8 million is immaterial and represents a tiny fraction of the company's value.
  • Ownership Concentration: The insider's total holdings of 35,178 shares constitute approximately 0.034% of total shares outstanding, indicating a low level of ownership concentration for this specific executive.
  • Transaction Significance: The transaction's value and share count are well below the thresholds for moderate significance (0.1% of market cap or 0.1% of shares outstanding). The nature of the transaction (tax withholding) further reduces its importance as it does not reflect a discretionary investment decision by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was a non-discretionary disposition to cover tax liabilities (Code 'F'), not an open-market sale reflecting a change in the insider's sentiment towards the company's future prospects. The size is negligible relative to the company's market cap.

Volume & Sentiment

  • Expected Volume Impact: None. This is a routine corporate action and will not impact trading volume.
  • Sentiment Indicator: Neutral. The filing does not provide any bullish or bearish signals.

Additional Context

Transaction Notes

  • Special Circumstances: The transaction code 'F' explicitly states this was a 'Payment of tax liability by withholding securities'. This is a common practice where a company withholds shares to pay the taxes due when restricted stock units (RSUs) or other equity awards vest for an employee. It is not an active sale by the insider on the open market.
Topics:#SECFiling#InsiderTrading#REGN#Regeneron#Form4#StockMarket#Pharma#Biotech#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.